Reconnect Labs
Research ServicesView the employees at
Reconnect Labs-
Robin von Rotz PhD-Student, Universität Zürich
-
Greater Zurich Area
-
Rising Star
Dario-Alessandro Dornbierer Psychopharmacologist | Pharmaceutical Scientist | Startup Entrepreneur-
Top 5%
Davor Kosanic CEO & co-founder at Reconnect Labs, serial impact entrepreneur-
Rising Star
Daniel Claussen Serving High Impact High Growth Ventures-
Zurich, Zurich, Switzerland
-
Rising Star
Jennifer Ross-Jones Jurist / Environment and Sustainability Specialist-
Rising Star
Overview
Reconnect Labs is a Swiss, clinical stage pharmaceutical company developing Regenerative Therapeutics™ for mental health at the forefront of neuroscience and precision psychopharmacology. Led by neuroscientists from the University of Zurich Psychiatric University Clinic (PUKZH), Reconnect translates 30 years of in-human research and clinical practice to solve for the safety, efficacy and commercialization challenges of generation 1 psychoplastogens, Reconnect originated a portfolio of psychoactive formulations for affective and neurodegenerative disorders, chronic pain and insomnia.
-